The effects of Parabolan do not end with cutting and mass promotion. This steroid will promote enhanced muscular endurance better than most steroids. It will also dramatically improve the individual’s overall rate of recovery. The individual will not tire out as fast and he will recover from hard, intense exercise or activity at an accelerated rate. Due to the powerful androgenic activity, the individual will find this steroid also greatly promotes increases in strength. In fact, some may even notice a slight increase during a cutting phase. Of course, most all will find strength diminishes to a degree when cutting, but more of it will be protected when dieting than would be otherwise. Due to these effects of Parabolan, enhanced endurance, recovery and strength, it can be a fantastic steroid for athletic performance. However, some individuals report decreases in cardiovascular endurance. However, it WILL NOT affect everyone this way. Many will simply enjoy the positive effects of Parabolan.
Oxandrolone has been shown to improve lean muscle mass in patients with burns. Hepatic dysfunction is a known side effect of treatment with oxandrolone. The purpose of this study was to examine the incidence of hepatic dysfunction in our series of burn patients receiving oxandrolone. Fourteen patients who received oxandrolone (5 mg, n = 8; 10 mg, n = 6) were identified from our prospectively collected burn database. The records of 61 control patients also were reviewed. Demographics such as age, comorbidities, and burn size were recorded. The incidence of hepatic dysfunction was determined by the presence of abnormal liver function tests. The study and control groups were similar in age and burn size. Two of the eight (25%) oxandrolone patients receiving 5 mg and four of the six (67%) oxandrolone patients receiving 10 mg had evidence of hepatic dysfunction. Twenty six of the 61 (43%) control patients had evidence of hepatic dysfunction (P = NS). There appears no significant increased incidence of hepatic dysfunction in burn patients who received oxandrolone compared to those who did not.